About us
Medical Devices and Pharma LLC is a professional provider of expert regulatory consulting services for manufacturers of medical devices and pharmaceutical products regulated by the United States Food and Drug Administration (FDA), Health Canada, the European Union (EU), and globally.
This webpage not only provides regulatory information and assistance, but it is also a consumer-oriented resource designed to present timely safety news, helpful information, and analysis for users of medical devices and pharmaceutical products.
Our mission
The mission of Medical Devices and Pharma is to provide the highest quality personalized professional regulatory services to our clients, maintain vigilance and provide timely safety information to consumers of medical device and pharmaceutical products, and provide insight and guidance to companies in FDA-regulated industries regarding their products, processes, innovation, product safety, and enforcement.
Who We Serve
We proudly support:
- Medical Device Manufacturers seeking compliance with QMSR and ISO 13485
- Startups and SMEs navigating FDA regulatory requirements for the first time
- Regulatory and Quality Professionals looking to expand their expertise
- Educational Institutions preparing the next generation of regulatory experts
Regulatory and quality information at your fingertips
We designed the Medical Devices and Pharma website to present critical industry information in a well-organized and easy-to-navigate format. We stay up-to-date with regulatory agency announcements and activities, so visitors to the site will see current information about medical devices and pharmaceuticals.
Contact us
We are available to respond to regulatory questions, strategies, or managed projects. Do you have regulatory questions about your medical device or pharmaceutical product? Let us know – please contact us and we can provide regulatory guidance and advice for upcoming regulatory projects.
Regulatory and Quality Headlines
Orthopedics Industry Consolidation
Consolidation in the Implantable Orthopedics Industry: A Historical Perspective Early Growth and Initial Consolidation (Pre-2000s) The orthopedic implant industry experienced significant growth in the late 20th century, driven by advancements in medical technology...
How Unsafe Medical Devices Can Slip Through the Cracks
Healthcare professionals and the device industry share responsibility for timely adverse event reportingGlobal device market withdrawals not always followed in US In a world of global trade and instant communication, you might assume that a medical device deemed...
Study Reveals Delays in Medical Device Adverse Event Reporting
Healthcare professionals and the device industry share responsibility for timely adverse event reportingLapses defeat the purpose of adverse event reporting A recent study published in the British Medical Journal has spotlighted a troubling trend: many medical device...
QMSR Strategy for US Companies with QSR and ISO Compliance
QMSR Implementation Strategy for U.S. Medical Device Manufacturers Compliant with the QSR and ISO 14385:2016 If your company is already compliant with the QSR and ISO 13485:2016, you’re ahead of the curve in the transition to FDA’s Quality Management System Regulation...
A QSR to QMSR Transition Strategy
QMSR Implementation Strategy for U.S. Medical Device Manufacturers Not in Compliance with ISO 14385:2016 Transitioning from the FDA’s Quality System Regulation (QSR; 21 CFR 820) to the Quality Management System Regulation (QMSR) is a significant undertaking that...
QSR-to-QMSR Paper Gap Audit
Is Your Quality System Really Ready for QMSR? As FDA’s transition from the QSR to the QMSR approaches, many medical device manufacturers are discovering that “substantially equivalent” doesn’t mean “completely aligned.” Even companies with solid QSR documentation are...
Postmarket Surveillance – from QSR to QMSR
How QSR Postmarket Surveillance Will Evolve Under the QMSR As medical device manufacturers transition from the FDA’s Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR), one area undergoing significant change is postmarket...
Postmarket Surveillance
What is Postmarket Surveillance (PMS)? Postmarket surveillance (PMS) refers to all activities carried out by manufacturers to monitor the performance, safety, and effectiveness of a medical device after it has been placed on the market. It includes collecting and...
Medical Device Labeling
In the world of medical devices, proper labeling isn't just a regulatory requirement, it is a vital component of patient safety, product usability, and market access. Whether you're a manufacturer navigating FDA regulations, a distributor handling multilingual...
QMSR Clause 8 – Measurement Analysis and Improvement
ISO 13485 Clause 8 Transition Notes The QMSR eliminates FDA-specific structure in favor of ISO 13485:2016 clauses. All above ISO 13485 clauses are now explicit requirements under QMSR. New documentation and risk-based decision-making are emphasized throughout the...